These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Mother-Newborn Pairs in Malawi Have Similar Antibody Repertoires to Diverse Malaria Antigens. Boudová S; Walldorf JA; Bailey JA; Divala T; Mungwira R; Mawindo P; Pablo J; Jasinskas A; Nakajima R; Ouattara A; Adams M; Felgner PL; Plowe CV; Travassos MA; Laufer MK Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28835359 [TBL] [Abstract][Full Text] [Related]
27. Comparison of functional assays used in the clinical development of a placental malaria vaccine. Pehrson C; Heno KK; Adams Y; Resende M; Mathiesen L; Soegaard M; de Jongh WA; Theander TG; Salanti A; Nielsen MA Vaccine; 2017 Jan; 35(4):610-618. PubMed ID: 28012775 [TBL] [Abstract][Full Text] [Related]
28. High-Throughput Testing of Antibody-Dependent Binding Inhibition of Placental Malaria Parasites. Nielsen MA; Salanti A Methods Mol Biol; 2015; 1325():241-53. PubMed ID: 26450394 [TBL] [Abstract][Full Text] [Related]
29. Of mice and women: rodent models of placental malaria. Hviid L; Marinho CR; Staalsoe T; Penha-Gonçalves C Trends Parasitol; 2010 Aug; 26(8):412-9. PubMed ID: 20605743 [TBL] [Abstract][Full Text] [Related]
32. Differential adhesion-inhibitory patterns of antibodies raised against two major variants of the NTS-DBL2X region of VAR2CSA. Doritchamou J; Bigey P; Nielsen MA; Gnidehou S; Ezinmegnon S; Burgain A; Massougbodji A; Deloron P; Salanti A; Ndam NT Vaccine; 2013 Sep; 31(41):4516-22. PubMed ID: 23933341 [TBL] [Abstract][Full Text] [Related]
33. High efficacy of anti DBL4ɛ-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women. Magistrado PA; Minja D; Doritchamou J; Ndam NT; John D; Schmiegelow C; Massougbodji A; Dahlbäck M; Ditlev SB; Pinto VV; Resende M; Lusingu J; Theander TG; Salanti A; Nielsen MA Vaccine; 2011 Jan; 29(3):437-43. PubMed ID: 21075162 [TBL] [Abstract][Full Text] [Related]
34. VAR2CSA and protective immunity against pregnancy-associated Plasmodium falciparum malaria. Hviid L; Salanti A Parasitology; 2007; 134(Pt 13):1871-6. PubMed ID: 17958922 [TBL] [Abstract][Full Text] [Related]
35. Functional genomic technologies applied to the control of the human malaria parasite, Plasmodium falciparum. Carucci DJ Pharmacogenomics; 2001 May; 2(2):137-42. PubMed ID: 11368752 [TBL] [Abstract][Full Text] [Related]
36. Preclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC. Chêne A; Gangnard S; Guadall A; Ginisty H; Leroy O; Havelange N; Viebig NK; Gamain B EBioMedicine; 2019 Apr; 42():145-156. PubMed ID: 30885725 [TBL] [Abstract][Full Text] [Related]
37. The use of transgenic parasites in malaria vaccine research. Othman AS; Marin-Mogollon C; Salman AM; Franke-Fayard BM; Janse CJ; Khan SM Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525963 [TBL] [Abstract][Full Text] [Related]
38. Improved pregnancy outcomes in women exposed to malaria with high antibody levels against Plasmodium falciparum. Mayor A; Kumar U; Bardají A; Gupta P; Jiménez A; Hamad A; Sigaúque B; Singh B; Quintó L; Kumar S; Gupta PK; Chauhan VS; Dobaño C; Alonso PL; Menéndez C; Chitnis CE J Infect Dis; 2013 Jun; 207(11):1664-74. PubMed ID: 23448726 [TBL] [Abstract][Full Text] [Related]
39. Decreased susceptibility to Plasmodium falciparum infection in pregnant women with iron deficiency. Kabyemela ER; Fried M; Kurtis JD; Mutabingwa TK; Duffy PE J Infect Dis; 2008 Jul; 198(2):163-6. PubMed ID: 18500927 [TBL] [Abstract][Full Text] [Related]
40. High level of var2csa transcription by Plasmodium falciparum isolated from the placenta. Tuikue Ndam NG; Salanti A; Bertin G; Dahlbäck M; Fievet N; Turner L; Gaye A; Theander T; Deloron P J Infect Dis; 2005 Jul; 192(2):331-5. PubMed ID: 15962229 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]